Azaspirocycles, which are nitrogen-containing spirocyclic scaffolds, play significant roles in synthetic and medicinal chemistry. Literature searches on azaspirocyclic scaffolds have shown that these derivatives possess a broad spectrum of biological and pharmacological properties such as antimitotic, cytotoxic, antibacterial, antimicrobial, ant-inflammatory, antioxidative and antidepressant activities. 1 A few examples of natural and synthetic drugs containing an azaspirocyclic skeleton are shown in Figure 1 . 2 Consequently, great efforts have been made to synthesize diverse azaspirocycles libraries to facilitate the incorporation of these moieties into more biologically and pharmaceutically active molecules.
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Among the recently synthesized azaspirocycle-containing compounds, azaspiro[4.5]trienones have attracted a great deal of attention due to their chemistry and their biological activities. 8 Very recently, and in the light of the intense interest to develop constrained tamoxifen mimics, Srivastava et al. reported azaspiro[4,5]trienones as novel scaffolds for anticancer drug development ( Figure 2 , top structure). 9 Furthermore, these compounds serve as valuable intermediates for the construction of azaspiro-fused tricyclic cores with promising anticancer activity by inducing DNA damage (Figure 2) . [10] [11] [12] Therefore, more attention has been drawn to the synthesis of functionalized azaspiro[4.5]trienones suitable for further derivatization processes. [13] [14] [15] Brominated substrates are excellent synthons for further functionalization because they can be further used in well-established cross-coupling reactions, whereas other approaches to such transformations are complex and often result in significant by-product formation. 16 In this respect, especially in light of the fact that brominated triene-diones are ideal scaffolds for further elaboration in the diversityoriented synthesis, Qiu et al. have recently described the synthesis of 3-bromo-1-azaspiro[4.5]deca-3,6,9-triene-2,8-dione through a novel ZnBr 2 -promoted oxidative ipso-annulation of N-arylpropiolamide.
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In light of these findings and as a result of our interest in combination of the Ugi four-component reaction (Ugi-4CR) with efficient post-transformations for generating complex and diverse molecular libraries, 17 we wish to report herein, a simple procedure for the synthesis of fully functionalized 3-bromoazaspiro[4.5]trienones via Ugi-4CR followed by ipso-bromocyclization. (Scheme 1).
Ugi 4-CR of 4-methoxybenzaldehyde (1a), aniline (2a), phenylpropiolic acid (3), and tert-butyl isocyanide (4a) in methanol at room temperature furnished the corresponding Ugi adduct 5a in 83% yield. This compound was chosen as the model substrate to investigate the bromine-mediated ipso-cyclization conditions. Application of (NH 4 ) 2 S 2 O 8 /TBHP (3 equiv/5 equiv) as the oxidant in the presence of N-methylmorpholine (NMM, 0.5 equiv) in acetonitrile at 80 °C under argon atmosphere produced the desired product 6a with a yield of 88%. After screening solvents under these conditions, acetonitrile was found to be the best solvent (Table 1 , entries 1-7). When N-methyl-2-pyrrolidone (NMP) was used in place of NMM, a marginal decrease in yield was recorded (entry 8). The application of NMM gave 6a with a yield of 88%, while replacement with triethylamine (TEA), 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) and N,N-diisopropylethylamine (DIEA) resulted in lower yields (entries 9-11). Other radical initiators including di-tert-butyl peroxide (DTBP), benzoyl peroxide (BP), and m-chloroperoxybenzoic acid (m-CPBA) were then employed, but all failed to give satisfactory yields (entries [12] [13] [14] .
After carrying out the Ugi 4-CR, the solvent was evaporated under reduced pressure, and the conditions were switched for the bromine-mediated ipso-cyclization, which gave compound 6a in 67% overall yield, comparable with the 73% total yield obtained in the two-step procedure. Subsequently, the scope of the reaction was investigated by using different aromatic aldehydes, anilines, and isocyanides (Scheme 2). 18 The structures of the products were confirmed based on NMR spectroscopy and HRMS (ESI) analysis. The characteristic resonances in the 1 H NMR spectra of all synthesized compounds appeared as four double doublets with coupling constants 9.9 and 1.8 Hz for the sp 2 C-H. The 13 C NMR spec- Initially, the effect of ring substituents on the aromatic aldehydes 6a-f was examined. Both electron-donating and electron-withdrawing substituents on the phenyl ring were tolerated as outlined (Scheme 2). With regard to the isocyanide component, tert-butyl isocyanide furnished the desired products in better yields than cyclohexyl isocyanide. A survey of aniline derivatives with differing substitution patterns revealed that aniline derivatives bearing substituents at the ortho-position were consistent with the optimal conditions, providing 6m and 6n in moderate to good yields.
Treatment of para-halogen-substituted anilines with 4-chlorobenzaldehyde (1b), phenylpropiolic acid (3), and tertbutyl isocyanide (4a) delivered product 6b, but he reaction did not proceed at all when the aniline ring contained a para-nitro group (Scheme 3). It is noteworthy that, in all cases where yields were lower than average, the reaction was inefficient at the ipso-bromocyclization step, with a complex mixture of products being obtained. 
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Scheme 3 The effect of halogen substituents on the aniline ring at the para-position 
Crude products were purified on a silica gel column (EtOAc/n-hexane, 1:5) and the purified compounds were fully characterized by IR, 1 H NMR, 13 C NMR spectroscopy and HRMS analysis. In addition, in the case 6a, the structure was confirmed by single-crystal X-ray diffraction analysis (Figure 3) .
Figure 3 ORTEP view of compound 6a
The proposed reaction mechanism involves the formation of vinyl radical I through the addition of a bromo radical generated from NBS and (NH 4 ) 2 S 2 O 8 to the alkyne group of the Ugi product. Subsequent intramolecular radical cyclization yields the intermediate II. Trapping of the radical intermediate II by the tert-butylperoxy radical generated from TBHP, and then elimination of tert-butyl alcohol provides the desired product (Scheme 4).
In conclusion, we have prepared a diverse array of fully functionalized 3-bromoazaspiro[4.5]trienones through Ugi-4CR followed by ipso-bromocyclization. Considering the biological importance of azaspiro[4.5]trienones and the potential utility of the bromo organic compounds to partake in further modifications, these compounds can be further exploited in the synthesis of lead compounds in medicinal chemistry.
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Supporting information for this article is available online at https://doi.org/10.1055/s-0037-1610205. S u p p o r t i n g I n f o r m a t i o n S u p p o r t i n g I n f o r m a t i o n pounds 6a-o; General Procedure To a solution of aldehyde 1a (1 mmol) in methanol (5 mL) was added aniline 2a (1 mmol), and the reaction mixture was stirred at room temperature for 2 h. Then, phenylpropiolic acid 3a (1 mmol) was added and stirring was continued for 15 min, followed by addition of isocyanide 4a (1 mmol); the solution was then stirred for 24 h at room temperature. The solvent was removed under reduced pressure and MeCN (10 mL) was added to the residue. N-Bromosuccinimide (1.5 mmol), (NH 4 ) 2 S 2 O 8 (3 mmol), TBHP (5 mmol) and NMM (0.5 mmol) were added and the reaction mixture was stirred at 80 °C for 12 h under an argon atmosphere. The progress of the reaction was monitored using TLC (n-hexane-EtOAc, 5:1). The resulting reaction mixture was concentrated under reduced pressure and the residue was purified by column chromatography (silica gel, appropriate mixture of n-hexane/ethyl acetate) to afford 6a. Bromo-2,8-dioxo-4-phenyl-1-azaspiro[4.5]deca-3,6,9-trien-1-yl)-N-(tert-butyl)-2-(4-methoxyphenyl) 
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